mgus with multiple paraproteins: results from the population-based istopmm screening study
Published 1 year ago • 839 plays • Length 8:07Download video MP4
Download video MP3
Similar videos
-
5:55
mgus and risk of chronic kidney disease: results of the population-based istopmm study
-
5:42
hypercalcemia in individuals with mgus: results from the istopmm study
-
8:14
autoimmune diseases are not associated with mgus: results of the population-based istopmm
-
8:02
screening for monoclonal gammopathy of undetermined significance: first results from istopmm study
-
4:13
estimating selection bias in previous mgus research-the importance of screening results from istopmm
-
6:00
istopmm - one year update
-
11:22
monoclonal gammopathy of undetermined significance and covid-19: results from istopmm
-
9:17
does sars-cov-2 vaccination impact the risk of progression from mgus to multiple myeloma?
-
4:51
mgus and thrombotic events: istopmm study results | sæmundur rögnvaldsson, md, phd | ash 2023
-
0:42
istopmm: a new, large & unbiased mgus patient population
-
2:47
istopmm analysis results: autoimmune diseases are not associated with mgus
-
1:53
istopmm study and early mgus and smm screening | joshua richter, md | ash 2021
-
59:27
imwg conference series: reporting from ash 2022
-
2:10
results of istopmm: prevalence of smoldering myeloma in the general population
-
2:59
what is mgus?
-
3:22
are mgus patients at higher risk of getting severely ill from covid-19?
-
5:07
should individuals dx with mgus or smm be receiving bisphosphonates?
-
3:46
istopmm (iceland screens, treats, or prevents multiple myeloma)
-
1:02:06
interpreting mgus/smoldering myeloma labs- what to know and when to take action